Scientific article
OA Policy
English

Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome

ContributorsSztajzel, Roman
Published inCirculation, vol. 132, no. 13, p. 1261-1269
Publication date2015
Abstract

We explored the safety of intravenous thrombolysis (IVT) or intra-arterial treatment (IAT) in patients with ischemic stroke on non-vitamin K antagonist oral anticoagulants (NOACs, last intake <48 hours) in comparison with patients (1) taking vitamin K antagonists (VKAs) or (2) without previous anticoagulation (no-OAC).

Keywords
  • Acute Disease
  • Administration
  • Oral
  • Aged
  • 80 and over
  • Anticoagulants/administration & dosage/adverse effects/classification/therapeutic use
  • Antithrombins/administration & dosage/adverse effects/therapeutic use
  • Atrial Fibrillation/complications
  • Brain Ischemia/blood/drug therapy
  • Cerebral Hemorrhage/chemically induced/epidemiology
  • Cohort Studies
  • Factor Xa Inhibitors/administration & dosage/adverse effects/therapeutic use
  • Female
  • Fibrinolytic Agents/therapeutic use
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Pilot Projects
  • Thrombolytic Therapy
  • Treatment Outcome
  • Vitamin K/antagonists & inhibitors
Citation (ISO format)
SZTAJZEL, Roman. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome. In: Circulation, 2015, vol. 132, n° 13, p. 1261–1269. doi: 10.1161/CIRCULATIONAHA.115.015484
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Journal ISSN0009-7322
420views
836downloads

Technical informations

Creation11/25/2016 3:02:00 PM
First validation11/25/2016 3:02:00 PM
Update time03/15/2023 1:12:21 AM
Status update03/15/2023 1:12:20 AM
Last indexation10/31/2024 5:40:18 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack